Online ECHO Clinic | August 6, 2020

Presentation Title: Substance Use Disorders: Brains, Behavior & Diagnosis

Dr. Jonathan Robbins, an Assistant Professor of Medicine at Oregon Health & Science University, shares information to help interpret a “negative” benzodiazepine urine drug screen, discusses how to the determine next steps for further confirmatory testing and how to recognize the emergence of novel psychoactive substances, as well as the challenges of monitoring and reporting in a rapidly changing drug-use landscape.


Presenter Bios

Jonathan Robbins, MD, MS, is an internal medicine doctor at Oregon Health & Science University. He has a special interest in the treatment of people with opioid use disorders, including those struggling with homelessness. He also instructs primary care doctors throughout Oregon on how to improve their ability to diagnose, treat and manage patients with persistent pain and opioid-use disorder.

Presentation Slides

KRATOM: It Must Be Safe Because It Comes From a Plant, Man

Resources Shared

Use of Buprenorphine-Naloxone in Pregnancy

Buprenorphine for Opioid Use Disorders During Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines